Intel has surged past its average analyst price target after one of its biggest monthly runs in years, and now bulls and bears are locked in a standoff over whether the turnaround still has…
Most widows sign the rollover form the same week their husband dies, not knowing that a single word to the custodian could control whether the IRS can touch that account for years.
Alphabet just posted numbers that should have sent the stock soaring, yet something is keeping a lid on it. Here is why the cheapest mega-cap in the AI trade might still have the most…
Both McDonald's and Starbucks trail the 10-year Treasury yield right now, so picking the wrong one doesn't just mean slower growth. It means betting a retirement portfolio on a payout that might not survive…
A regulatory probe into rival AI startups sent Alibaba sliding even though Beijing named no Alibaba products, and traders are now wrestling with how far the scrutiny could spread across China's model layer.
Intuit has shed more than half its value while peers like ADP and Paychex held steady or climbed, leaving analysts split on whether a cratered franchise is a generational buying opportunity or the first…
Wall Street analysts are fighting over Micron more violently than they have in years, with targets ranging from a humble hold to a stunning $2,000 price, and a single line in the September 30…
IonQ just dropped two back-to-back announcements that sent its stock surging while the broader quantum ETF slipped, and the reason one company is pulling so far away from the pack reveals something important about…
AMD just crossed a milestone that chip investors rarely live to see twice, and Wall Street is still scrambling to catch up. Here is the specific scenario that puts shares at a number most…
Two S&P 500 funds hold nearly identical stocks, yet their returns have drifted so far apart over a decade that the gap itself tells a story about what most investors misunderstand about diversification.
Paradigm's revelation that it holds Zcash sent shockwaves through the crypto market, but the timeline raises a provocative question about who really drove this rally and whether new buyers are walking into a trap.
Patent cliffs have buried lesser pharma dividends, yet these four Big Pharma giants keep raising payouts despite losing blockbuster exclusivities worth billions. Find out which one has held its streak for 64 straight years…
A dividend can be slashed the moment a board votes to cut it, but not every guaranteed alternative actually guarantees what investors assume. Before you choose income over certainty or certainty over income, the…
Nvidia just posted triple-digit revenue growth and Jensen Huang says the company can only fulfill 70% of demand, yet the stock still trades well below where the math points. Three converging forces suggest the…
New York recognizes a legal mechanism that lets a well spouse refuse to pay for nursing home care without losing Medicaid coverage for the sick one, but the letter you sign in the morning…
